NCT05872165

Brief Summary

Comparison between 2 groups of chronic lateral epicondylitis, to determine the effect of ozonated media phonophoresis on chronic lateral epicondylitis.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 12, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 24, 2023

Completed
8 days until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

May 24, 2023

Status Verified

May 1, 2023

Enrollment Period

2 months

First QC Date

May 12, 2023

Last Update Submit

May 22, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Pain status

    assessment of pain using (visual analogue scale)s a horizontal line, 100 mm in length, anchored by word descriptors at each end. 2) The patient mark millimeters ed on the line the point that they feel ed represents their perception of their current state. The VAS score is determined by measuring in from the start point of the line to the point that the patient marks It was used to evaluate pain intensity. The VAS is a self. reported pain meas urement scale. The extremes of the line are labelled as no pain and worst pain. Each subject was asked to mark the point on the line that exactly corresponded to his/her pain .

    4 weeks

  • wrist ROM

    Measurment of wrist range of motion using universal goniometer

    4 weeks

  • Hand grip strength

    measurment of hand grip strength using hand grip dynamometer

    4 weeks

Study Arms (2)

Experimental group

EXPERIMENTAL

this group of 20 subjects will receive the ozonated media phonophoresis plus conventional physical therapy program 3 times weekly for 4 weeks.

Device: phonophoresisOther: conventional physical therapy

Control group

OTHER

this group of 20 subjects will receive only conventional physical therapy program 3 times weekly for 4 weeks.

Other: conventional physical therapy

Interventions

1 MHz, 1 W/cm2continuous mode of ultrasound therapy for 5 min. using ozonated gel as a coupling medium

Also known as: Ultrasound with ozonated medium gel
Experimental group

conventional TENS (100 Hz) for 30 min - hot pack for 20 min- stretching and strengthening exercises, wrist rest splints 3times per week for 4 weeks.

Also known as: Tens and exercises
Control groupExperimental group

Eligibility Criteria

Age30 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All patients would be diagnosed as chronic lateral epicondylitis from both genders.
  • Patients with chronic lateral epicondylitis that diagnosed by orthopedist.
  • Positive clinical manifestation in all patients.
  • Pain onset is more than 3 months.
  • All participants must be medically stable and not be treated with analgesics or any medication which may cause misleading results.
  • All patients had body mass index between 18.5 and 29.9 kg/m2.

You may not qualify if:

  • Subjects would be excluded if they have:
  • Received intra articular injection from duration less than 3 months.
  • Elbow instability.
  • History of cancer.
  • Pregnancy
  • Infection.
  • Skin diseases on elbow area.
  • Open wound in elbow.
  • Shoulder or elbow fractures
  • Systemic diseases such as rheumatoid arthritis, Reiter's syndrome, or diabetes.
  • Neurological diseases.
  • Severe medical or psychiatric disorders.
  • Elbow surgery.
  • Entrapment of the radial nerve.
  • Arthritis and effusion of the elbow.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

PhonophoresisUltrasonographyTranscutaneous Electric Nerve StimulationExercise

Intervention Hierarchy (Ancestors)

Drug Administration RoutesDrug TherapyTherapeuticsDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and AnalgesiaMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
physical therapist

Study Record Dates

First Submitted

May 12, 2023

First Posted

May 24, 2023

Study Start

June 1, 2023

Primary Completion

August 1, 2023

Study Completion

September 1, 2023

Last Updated

May 24, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

think to share after request.